Use of c-Src inhibitors in combination with a pyrimidylaminobenzamide compound for the treatment of leukemia
A Standard patent application filed on credited to Paul W., Manley

Details

Application number :

2013201915  

Application type :

Standard  

Application status :

FILED  

Under opposition :

No  

Proceeding type :

 

Invention title :

Use of c-Src inhibitors in combination with a pyrimidylaminobenzamide compound for the treatment of leukemia  

Inventor :

Paul W., Manley  

Agent name :

Davies Collison Cave  

Address for service :

 

Filing date :

 

Associated companies :

 

Applicant name :

 

Applicant address :

 

Old name :

 

Original Source :

Go  

Same Inventor

• Pharmaceutical combination of Bcr-Abl and RAF inhibitors
• Improvements in or relating to organic compounds
• 4-carboxamido-6(pyridin-4-yl substituted benzopyran derivatives
• Benzopyrans and pharmaceutical compositions containing them
• Combinations of JAK inhibitors and at least one of Bcr-Abl, Flt-3,...